ROCKLAND, Mass.--(BUSINESS WIRE)--BioSphere Medical, Inc. (NASDAQ: BSMD), the medical device company that pioneered the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a procedure called embolization, announced today that Martin Joyce, Executive Vice President and Chief Financial Officer, is scheduled to present at the Roth 2007 New York Conference at 9:00 a.m. ET on Thursday, September 6, 2007. The event is taking place at the Westin Times Square in New York City.
